Ophthalmology Billing Guide 2026: Cataract Surgery, Retinal Procedures, and Eye Exam Coding

Published June 12, 2026 · 13 min read · By RCMAXIS Revenue Cycle Team

Ophthalmology sits at a unique intersection in medical billing: it combines the complexity of surgical procedure coding with a distinct eye examination code set that does not use standard E/M codes, plus high-dollar diagnostic imaging (OCT, visual fields), and one of the most procedure-intensive outpatient surgical environments in medicine. The average ophthalmology practice runs a 10.4% denial rate, with the primary drivers being wrong eye modifier (bilateral vs. unilateral), cataract surgery global period violations, and OCT medical necessity documentation failures.

This guide covers the six most revenue-critical billing categories in ophthalmology: eye examination codes, cataract surgery coding, retinal procedure billing, glaucoma treatment codes, diagnostic imaging (OCT and visual fields), and the modifier rules that determine whether you collect on bilateral procedures.

1. Eye Examination Codes: The 92000 Series vs. E/M

Ophthalmology uses a dedicated examination code set (92002–92014) instead of standard office visit E/M codes (99202–99215). These codes are specific to eye examinations and reflect the scope of the ocular evaluation rather than the complexity framework used in general medicine.

When to Use E/M Instead of 92000-Series

Ophthalmologists may use either the 92000-series codes OR standard E/M codes (99202–99215), but not both on the same date for the same problem. Key guidance:

• Use 92004/92014 for routine eye exams, glasses/contact evaluations, and ocular disease management — the scope is defined by the ophthalmological examination elements
• Use E/M codes (99202–99215) when the visit is primarily medical in nature and uses the standard MDM or time-based framework — for example, managing a patient's systemic hypertensive retinopathy with multiple co-morbidities
• Do NOT use 92000-series and E/M on the same date for the same patient — payers will bundle one of them
• Medicare Vision vs. Medical: Medicare Part B covers medically necessary eye exams; routine vision exams are Part B only if there is a diagnosed eye disease (diabetic retinopathy, glaucoma, AMD) — the ICD-10 diagnosis drives coverage determination

2. Cataract Surgery Billing

Cataract surgery (CPT 66984, 66982) is the highest-volume surgical procedure in Medicare and the most audited procedure in ophthalmology. The surgery carries a 90-day global period, meaning all routine post-operative care for 90 days after surgery is included in the surgical fee — do not bill separately for post-op visits.

Premium IOL and Patient Responsibility

When a patient elects a premium IOL (toric for astigmatism correction, multifocal/extended depth of focus for presbyopia), the premium IOL difference and the additional physician services associated with premium technology are not covered by Medicare/most insurers and are billed directly to the patient:

• The base IOL and standard surgical fee (66984) are billed to insurance as usual
• The premium technology upcharge — typically $800–$2,000 per eye — is collected as an advance beneficiary notice (ABN) charge directly from the patient
• Ensure the patient signs an ABN specifically documenting the premium IOL election and patient financial responsibility before surgery
• Bill modifier -LT (left eye) or -RT (right eye) on all unilateral cataract procedures; second-eye surgery is billed with modifier 79 (unrelated procedure during post-op period) if within the 90-day global of the first eye

3. Retinal Procedure Billing

Retinal procedures span a wide range from office-based injections (anti-VEGF, steroid) to complex surgical vitrectomies, each with specific billing rules around laterality, drug coding, and bundling restrictions.

Anti-VEGF Injection Billing: The Buy-and-Bill Model

Anti-VEGF injections represent the highest revenue category in most retinal practices. The buy-and-bill model requires precision on drug quantity documentation:

• Bill 67028 for the injection + the J-code for the specific drug with exact units administered
• Aflibercept (J0178): 2 mg dose = 2 units; ranibizumab (J2778): 0.5 mg dose = 5 units (billed per 0.1 mg)
• Same-day OCT and fundus photography with the injection are separately billable with medical necessity documentation
• Bilateral injections on the same day: bill 67028-50 (bilateral modifier) for most payers, or 67028-LT and 67028-RT on separate lines — verify payer preference

4. Glaucoma Billing

Glaucoma management generates recurring revenue through office visits, visual field testing, OCT of the optic nerve, and procedural interventions. The ICD-10 code specificity for glaucoma type and stage directly impacts coverage authorization.

5. OCT Billing: Medical Necessity is Everything

Optical Coherence Tomography (OCT) is the highest-volume diagnostic test in ophthalmology — and the most frequently denied. Every OCT claim must have documented medical necessity tied to a specific diagnosis that justifies imaging.

• 92134: SCODI, posterior segment — retina (the most commonly billed OCT code for retinal disease: AMD, diabetic macular edema, retinal vein occlusion)
• 92133: SCODI, posterior segment — optic nerve (glaucoma monitoring)
• Do not bill both 92133 and 92134 on the same date without strong clinical justification — payers frequently deny both when billed together without clear documentation of why both are needed
• Frequency: Medicare allows OCT every 12 months for routine AMD monitoring; more frequent OCT requires documentation of clinical change (new symptoms, vision change, fluid on prior OCT)
• ICD-10 specificity: use the specific retinal condition code (H35.31 for nonexudative AMD, H35.32 for exudative AMD, H36.0 for diabetic macular edema) — unspecified codes trigger medical necessity review

6. Modifier Rules: Bilateral, Global Period, and Same-Day Procedures

Modifier errors are the #1 cause of ophthalmology denials. Three modifier rules govern the majority of ophthalmology billing:

Laterality Modifiers (LT/RT vs. 50)

• Medicare: bill bilateral procedures on two separate claim lines with -LT and -RT modifiers; Medicare does not accept modifier 50 on most ophthalmic procedures
• Commercial payers: most prefer modifier -50 on one line for bilateral procedures; verify by payer contract
• Always apply laterality to: cataract surgery, laser procedures, intravitreal injections, visual fields, and OCT when performed bilaterally

Global Period Rules (90-Day for Cataracts)

• Post-operative visits within the 90-day global of cataract surgery are included in the surgical fee — do not bill 92012 or 92014 for routine post-op checks
• If the post-op visit addresses a new, unrelated problem (different eye condition, systemic issue), bill the visit with modifier -24 (unrelated E/M during post-op period)
• Second-eye cataract during the 90-day global of the first: bill 66984-RT (or LT) with modifier -79 (unrelated procedure during post-op period)

Same-Day Procedure + Office Visit (Modifier 25)

• When a significant, separately documented E/M (or 92012/92014) occurs on the same day as a minor procedure (injection, laser), the E/M requires modifier -25
• The examination that serves as the basis for deciding to perform the procedure does NOT qualify as a separate E/M — it must be a distinct evaluation beyond what is required for the procedure consent

RCMAXIS ophthalmology billing specialists hold CPCO (Certified Professional Coder — Ophthalmology) credentials and manage the full billing lifecycle from eligibility verification through surgical global period tracking. Start with a free revenue assessment to benchmark your current denial rate against ophthalmology peers.